Alzheimer Disease: New Drugs in the Offing?

What medications are in the pipeline that may help slow or even prevent the development of Alzheimer disease?

Here, Howard Fillit, MD, Founding Executive Director and Chief Science Officer of the Alzheimer's Drug Discovery Foundation, talks briefly about the most promising drugs-and the role of the ADDF in helping to bring those drugs through clinical trials.